基于风险模型的肺癌筛查与美国种族和民族差异
该队列研究纳入105 261名有吸烟史成人,验证并重新校准PLCOm2012模型(PLCOm2012-Update),比较其6年风险≥1.3%的风险筛查与USPSTF 2021标准在种族和民族间的筛查资格与性能。PLCOm2012-Update预测准确性良好(AUC 0.72-0.82),风险筛查较USPSTF 2021标准总体敏感性更高(67.2% vs 57.7%)、需筛查人数更少(26 vs 30),并大幅缩小非洲裔与白人间的差异。
要点
- PLCOm2012-Update在多种族人群中预测准确性良好,AUC为0.72-0.82。
- USPSTF 2021标准下非洲裔美国人资格-发病比白人低53%(9.5 vs 20.3)。
- 风险筛查使非洲裔与白人资格-发病比差距缩小(15.9 vs 18.4),其他少数族裔差异极小。
核心结论
- 基于风险的肺癌筛查可减少种族和民族差异,并较USPSTF 2021标准改善各人群筛查性能。
研究设计与样本
- 基于人群的队列设计,多种族队列研究于1993-1996年入组,随访至2018年12月31日。
- 共纳入105 261名有吸烟史成人(60 011名男性,占57.0%;平均年龄59.8岁,SD 8.7)。
- 数据分析于2022年4月1日至2023年5月19日进行。
主要发现
- 6年内共1464人(1.4%)发生肺癌。
- PLCOm2012-Update在各种族和民族中预测准确性良好(AUC 0.72-0.82)。
- USPSTF 2021标准下非洲裔美国人资格-发病比白人低53%(9.5 vs 20.3;P < .001)。
- 风险筛查(6年风险≥1.3%)下非洲裔与白人差异大幅缩小(资格-发病比15.9 vs 18.4;P < .001),其他少数族裔差异极小。
- 风险筛查总体敏感性高于USPSTF 2021标准(67.2% vs 57.7%),需筛查人数更少(26 vs 30),特异性相近(76.6%)。
关键数值与推荐
- 风险筛查资格定义为重新校准的PLCOm2012(PLCOm2012-Update)6年肺癌风险≥1.3%。
- USPSTF 2021标准下非洲裔美国人资格-发病比为9.5,白人20.3(P < .001)。
- 风险筛查下非洲裔美国人资格-发病比为15.9,白人18.4(P < .001)。
- 风险筛查总体敏感性67.2%,USPSTF 2021标准57.7%;需筛查人数26 vs 30;特异性76.6%。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: The revised 2021 US Preventive Services Task Force (USPSTF) guidelines for lung cancer screening have been shown to reduce disparities in screening eligibility and performance between African American and White individuals vs the 2013 guidelines. However, potential disparities across other racial and ethnic groups in the US remain unknown. Risk model-based screening may reduce racial and ethnic disparities and improve screening performance, but neither validation of key risk prediction models nor their screening performance has been examined by race and ethnicity. OBJECTIVE: To validate and recalibrate the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial 2012 (PLCOm2012) model-a well-established risk prediction model based on a predominantly White population-across races and ethnicities in the US and evaluate racial and ethnic disparities and screening performance through risk-based screening using PLCOm2012 vs the USPSTF 2021 criteria. DESIGN, SETTING, AND PARTICIPANTS: In a population-based cohort design, the Multiethnic Cohort Study enrolled participants in 1993-1996, followed up through December 31, 2018. Data analysis was conducted from April 1, 2022, to May 19. 2023. A total of 105 261 adults with a smoking history were included. EXPOSURES: The 6-year lung cancer risk was calculated through recalibrated PLCOm2012 (ie, PLCOm2012-Update) and screening eligibility based on a 6-year risk threshold greater than or equal to 1.3%, yielding similar eligibility as the USPSTF 2021 guidelines. OUTCOMES: Predictive accuracy, screening eligibility-incidence (E-I) ratio (ie, ratio of the number of eligible to incident cases), and screening performance (sensitivity, specificity, and number needed to screen to detect 1 lung cancer). RESULTS: Of 105 261 participants (60 011 [57.0%] men; mean [SD] age, 59.8 [8.7] years), consisting of 19 258 (18.3%) African American, 27 227 (25.9%) Japanese American, 21 383 (20.3%) Latino, 8368 (7.9%) Native Hawaiian/Other Pacific Islander, and 29 025 (27.6%) White individuals, 1464 (1.4%) developed lung cancer within 6 years from enrollment. The PLCOm2012-Update showed good predictive accuracy across races and ethnicities (area under the curve, 0.72-0.82). The USPSTF 2021 criteria yielded a large disparity among African American individuals, whose E-I ratio was 53% lower vs White individuals (E-I ratio: 9.5 vs 20.3; P < .001). Under the risk-based screening (PLCOm2012-Update 6-year risk ≥1.3%), the disparity between African American and White individuals was substantially reduced (E-I ratio: 15.9 vs 18.4; P < .001), with minimal disparities observed in persons of other minoritized groups, including Japanese American, Latino, and Native Hawaiian/Other Pacific Islander. Risk-based screening yielded superior overall and race and ethnicity-specific performance to the USPSTF 2021 criteria, with higher overall sensitivity (67.2% vs 57.7%) and lower number needed to screen (26 vs 30) at similar specificity (76.6%). CONCLUSIONS: The findings of this cohort study suggest that risk-based lung cancer screening can reduce racial and ethnic disparities and improve screening performance across races and ethnicities vs the USPSTF 2021 criteria.
引用
- Choi E, Ding VY, Luo SJ, et al. Risk Model-Based Lung Cancer Screening and Racial and Ethnic Disparities in the US. JAMA Oncol. 2023. PMID: 37883107. doi:10.1001/jamaoncol.2023.4447
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。